$SGMO Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in SANGAMO THERAPEUTICS, INC. Get notifications about new insider transactions in SANGAMO THERAPEUTICS, INC for free.

Page:   < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 16 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 10 2012SGMOSANGAMO BIOSCIENCE ...LANPHIER EDWARD O IIPresident & CEOGiftG0.0011,00001,559,7421.6 M to 1.6 M (-0.70 %)
Dec 10 2012SGMOSANGAMO BIOSCIENCE ...LANPHIER EDWARD O IIPresident & CEOGrantA0.00180,0000530,000350 K to 530 K (+51.43 %)
Dec 10 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...Option ExerciseA5.4170,000378,70070,000
Dec 10 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...GrantA0.0035,000090,79855.8 K to 90.8 K (+62.73 %)
Dec 10 2012SGMOSANGAMO BIOSCIENCE ...Wolff Henry WardExec VP & CFOOption ExerciseA5.4190,000486,90090,000
Dec 10 2012SGMOSANGAMO BIOSCIENCE ...Wolff Henry WardExec VP & CFOGrantA0.0045,0000211,219166.2 K to 211.2 K (+27.07 %)
Dec 10 2012SGMOSANGAMO BIOSCIENCE ...NICHOL GEOFFREYExecutive Vice Pres ...Option ExerciseA5.41110,000595,100110,000
Dec 10 2012SGMOSANGAMO BIOSCIENCE ...NICHOL GEOFFREYExecutive Vice Pres ...GrantA0.0055,0000130,00075 K to 130 K (+73.33 %)
Nov 28 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...Option ExerciseM3.6115,00054,15050,800
Nov 28 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.6015,00084,00055,79870.8 K to 55.8 K (-21.19 %)
Nov 28 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...BuyM3.6115,00054,15070,79855.8 K to 70.8 K (+26.88 %)
Nov 28 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.334,73625,23255,79860.5 K to 55.8 K (-7.82 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.717,50042,825208,160215.7 K to 208.2 K (-3.48 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.704002,280215,660216.1 K to 215.7 K (-0.19 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.696003,414216,060216.7 K to 216.1 K (-0.28 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.63100563216,660216.8 K to 216.7 K (-0.05 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.623001,686216,760217.1 K to 216.8 K (-0.14 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.611,80510,126217,060218.9 K to 217.1 K (-0.82 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.60100560218,865219 K to 218.9 K (-0.05 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.543,19517,700218,965222.2 K to 219 K (-1.44 %)
Dec 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.481,0005,480222,160223.2 K to 222.2 K (-0.45 %)
Nov 05 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.5215,00082,764223,160238.2 K to 223.2 K (-6.30 %)
Oct 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...Option ExerciseM3.6115,00054,15065,800
Oct 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.725,00028,60058,53463.5 K to 58.5 K (-7.87 %)
Oct 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.6915,00085,33563,53478.5 K to 63.5 K (-19.10 %)
Oct 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellM3.6115,00054,15078,53493.5 K to 78.5 K (-16.04 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...Gregory Philip DVP, Therapeutic Dev ...Option ExerciseM4.926,00029,52033,000
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...Gregory Philip DVP, Therapeutic Dev ...SellS6.006,00036,00050,00056 K to 50 K (-10.71 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...Gregory Philip DVP, Therapeutic Dev ...BuyM4.926,00029,52056,00050 K to 56 K (+12.00 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.621,5008,43063,53465 K to 63.5 K (-2.31 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.621,5008,43565,03466.5 K to 65 K (-2.25 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.693001,70866,53466.8 K to 66.5 K (-0.45 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.695002,84766,83467.3 K to 66.8 K (-0.74 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.701861,06067,33467.5 K to 67.3 K (-0.28 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.71148067,52067.5 K to 67.5 K (-0.02 %)
Oct 17 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.721,0005,72367,53468.5 K to 67.5 K (-1.46 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.241,3988,724238,160239.6 K to 238.2 K (-0.58 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.221,94012,067239,558241.5 K to 239.6 K (-0.80 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.216,67641,458241,498248.2 K to 241.5 K (-2.69 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.2058360248,174248.2 K to 248.2 K (-0.02 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.199956,159248,232249.2 K to 248.2 K (-0.40 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.181,2587,774249,227250.5 K to 249.2 K (-0.50 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.171,86911,532250,485252.4 K to 250.5 K (-0.74 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.165063,117252,354252.9 K to 252.4 K (-0.20 %)
Oct 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS6.153001,845252,860253.2 K to 252.9 K (-0.12 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.35100535253,160253.3 K to 253.2 K (-0.04 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.3499529253,260253.4 K to 253.3 K (-0.04 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.333001,599253,359253.7 K to 253.4 K (-0.12 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.321961,043253,659253.9 K to 253.7 K (-0.08 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.327,60340,448253,855261.5 K to 253.9 K (-2.91 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.318034,264261,458262.3 K to 261.5 K (-0.31 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.302,70214,321262,261265 K to 262.3 K (-1.02 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.274292,261264,963265.4 K to 265 K (-0.16 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.261,0685,618265,392266.5 K to 265.4 K (-0.40 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.252991,570266,460266.8 K to 266.5 K (-0.11 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.24100524266,759266.9 K to 266.8 K (-0.04 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.23100523266,859267 K to 266.9 K (-0.04 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.225002,610266,959267.5 K to 267 K (-0.19 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.216013,131267,459268.1 K to 267.5 K (-0.22 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.20100520268,060268.2 K to 268.1 K (-0.04 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...Option ExerciseM3.6115,00054,15080,800
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.6015,00084,00068,53483.5 K to 68.5 K (-17.96 %)
Sep 06 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...BuyM3.6115,00054,15083,53468.5 K to 83.5 K (+21.89 %)
Aug 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.287,90041,712268,160276.1 K to 268.2 K (-2.86 %)
Aug 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.271,5007,905276,060277.6 K to 276.1 K (-0.54 %)
Aug 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.26100526277,560277.7 K to 277.6 K (-0.04 %)
Aug 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.24100524277,660277.8 K to 277.7 K (-0.04 %)
Aug 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.238004,184277,760278.6 K to 277.8 K (-0.29 %)
Aug 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.221,5007,830278,560280.1 K to 278.6 K (-0.54 %)
Aug 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.212,40012,504280,060282.5 K to 280.1 K (-0.85 %)
Aug 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.207003,640282,460283.2 K to 282.5 K (-0.25 %)
Aug 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.232501,30868,53468.8 K to 68.5 K (-0.36 %)
Aug 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.222001,04468,78469 K to 68.8 K (-0.29 %)
Aug 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.221,0005,21668,98470 K to 69 K (-1.43 %)
Aug 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.215502,86669,98470.5 K to 70 K (-0.78 %)
Aug 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.172001,03470,53470.7 K to 70.5 K (-0.28 %)
Aug 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.161,6308,41170,73472.4 K to 70.7 K (-2.25 %)
Aug 29 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.151,1706,02672,36473.5 K to 72.4 K (-1.59 %)
Jul 30 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...Option ExerciseM3.6115,00054,15095,800
Jul 30 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.6015,00084,00073,53488.5 K to 73.5 K (-16.94 %)
Jul 30 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...BuyM3.6115,00054,15088,53473.5 K to 88.5 K (+20.40 %)
Jul 30 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS4.995002,49573,53474 K to 73.5 K (-0.68 %)
Jul 30 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.025002,51074,03474.5 K to 74 K (-0.67 %)
Jul 30 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.041,5007,56074,53476 K to 74.5 K (-1.97 %)
Jul 30 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.091,5007,63576,03477.5 K to 76 K (-1.93 %)
Jul 30 2012SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...SellS5.121,0005,12077,53478.5 K to 77.5 K (-1.27 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.293001,587283,160283.5 K to 283.2 K (-0.11 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.28100528283,460283.6 K to 283.5 K (-0.04 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.273591,892283,560283.9 K to 283.6 K (-0.13 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.262,50013,150283,919286.4 K to 283.9 K (-0.87 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.251,6008,400286,419288 K to 286.4 K (-0.56 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.244,10021,484288,019292.1 K to 288 K (-1.40 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.24100524292,119292.2 K to 292.1 K (-0.03 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.23100523292,219292.3 K to 292.2 K (-0.03 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.231,92710,078292,319294.2 K to 292.3 K (-0.65 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.22100522294,246294.3 K to 294.2 K (-0.03 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.221,4737,689294,346295.8 K to 294.3 K (-0.50 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.22100522295,819295.9 K to 295.8 K (-0.03 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.214002,084295,919296.3 K to 295.9 K (-0.13 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.21100521296,319296.4 K to 296.3 K (-0.03 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.202001,040296,419296.6 K to 296.4 K (-0.07 %)
Jul 03 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.201,5418,013296,619298.2 K to 296.6 K (-0.52 %)
Jun 25 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorOption ExerciseA5.0310,00050,30010,000
Jun 25 2012SGMOSANGAMO BIOSCIENCE ...Ramasastry SairaDirectorOption ExerciseA5.0350,000251,50050,000
Jun 25 2012SGMOSANGAMO BIOSCIENCE ...Cleveland Paul BDirectorOption ExerciseA5.0310,00050,30010,000
Jun 25 2012SGMOSANGAMO BIOSCIENCE ...DILLY STEPHEN GEORGEDirectorOption ExerciseA5.0310,00050,30010,000
Jun 25 2012SGMOSANGAMO BIOSCIENCE ...RINGO WILLIAM RDirectorOption ExerciseA5.0310,00050,30010,000
Jun 25 2012SGMOSANGAMO BIOSCIENCE ...Mento Steven JDirectorOption ExerciseA5.0310,00050,30010,000
Jun 19 2012SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorSellS5.0015,00075,000298,160313.2 K to 298.2 K (-4.79 %)
Jan 04 2012SGMOSANGAMO BIOSCIENCE ...Wolff Henry WardExec VP & CFOPayment of ExerciseF2.842,2346,345162,219164.5 K to 162.2 K (-1.36 %)
Oct 04 2011SGMOSANGAMO BIOSCIENCE ...Wolff Henry WardExec VP & CFOPayment of ExerciseF4.352,2349,71887,45389.7 K to 87.5 K (-2.49 %)
Dec 12 2011SGMOSANGAMO BIOSCIENCE ...LANPHIER EDWARD O IIPresident & CEOGiftG0.0015,00001,610,7421.6 M to 1.6 M (-0.92 %)
Dec 12 2011SGMOSANGAMO BIOSCIENCE ...LANPHIER EDWARD O IIPresident & CEOGrantA0.00150,0000350,000200 K to 350 K (+75.00 %)
Dec 12 2011SGMOSANGAMO BIOSCIENCE ...Wolff Henry WardExec VP & CFOGrantA0.0075,0000164,45389.5 K to 164.5 K (+83.84 %)
Dec 12 2011SGMOSANGAMO BIOSCIENCE ...NICHOL GEOFFREYExecutive Vice Pres ...GrantA0.0075,000075,0000 to 75 K
Dec 12 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...GrantA0.0050,000050,0000 to 50 K
Dec 12 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...GrantA0.0025,000025,0000 to 25 K
Dec 12 2011SGMOSANGAMO BIOSCIENCE ...ANDO DALE GVP, Therapeutic Dev ...GrantA0.0050,000076,53426.5 K to 76.5 K (+188.44 %)
Sep 13 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...Option ExerciseM3.002,5007,500141,709
Sep 13 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...SellS6.002,50015,00002.5 K to 0 (-100.00 %)
Sep 13 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...BuyM3.002,5007,5002,5000 to 2.5 K
Jul 11 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...Option ExerciseM5.194,00020,76057,068
Jul 11 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...SellS6.474,00025,88004 K to 0 (-100.00 %)
Jul 11 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...BuyM5.194,00020,7604,0000 to 4 K
Jul 11 2011SGMOSANGAMO BIOSCIENCE ...NICHOL GEOFFREYExecutive Vice Pres ...Option ExerciseA5.94300,0001,782,000300,000
Jul 05 2011SGMOSANGAMO BIOSCIENCE ...Wolff Henry WardExec VP & CFOPayment of ExerciseF5.892,23413,15889,68791.9 K to 89.7 K (-2.43 %)
Jul 05 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...Option ExerciseM3.4515,00051,750144,209
Jul 05 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...SellS6.0015,00090,000015 K to 0 (-100.00 %)
Jul 05 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...BuyM3.4515,00051,75015,0000 to 15 K
Jun 08 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...Option ExerciseM5.194,00020,76061,068
Jun 08 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...SellS6.524,00026,08004 K to 0 (-100.00 %)
Jun 08 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...BuyM5.194,00020,7604,0000 to 4 K
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...Cleveland Paul BDirectorOption ExerciseA6.4110,00064,10010,000
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...Mento Steven JDirectorOption ExerciseA6.4110,00064,10010,000
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...DILLY STEPHEN GEORGEDirectorOption ExerciseA6.4110,00064,10010,000
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...RINGO WILLIAM RDirectorOption ExerciseA6.4110,00064,10010,000
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...LARSON JOHN WILLIAMDirectorOption ExerciseA6.4110,00064,10010,000
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...WIGGANS THOMAS GDirectorOption ExerciseA6.4110,00064,10010,000
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...Option ExerciseM3.4515,00051,750159,209
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...SellS6.8013,89494,479013.9 K to 0 (-100.00 %)
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...SellS6.811,0006,81013,89414.9 K to 13.9 K (-6.71 %)
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...SellS6.8210672314,89415 K to 14.9 K (-0.71 %)
Jun 03 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...BuyM3.4515,00051,75015,0000 to 15 K
May 09 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...Option ExerciseM5.194,00020,76065,068
May 09 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...SellS6.744,00026,96004 K to 0 (-100.00 %)
May 09 2011SGMOSANGAMO BIOSCIENCE ...Ichikawa David GSenior VP, Bus. Dev ...BuyM5.194,00020,7604,0000 to 4 K
May 04 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...Option ExerciseM3.4515,00051,750174,209
May 04 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...SellS7.351007350100 to 0 (-100.00 %)
May 04 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...SellS7.347,40054,3161007.5 K to 100 (-98.67 %)
May 04 2011SGMOSANGAMO BIOSCIENCE ...Gregory Philip DCSO & Vice Presiden ...SellS7.342,20016,1377,5009.7 K to 7.5 K (-22.68 %)

Page:   < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 16 next >